Active ingredient
Everolimus NDC Codes
Everolimus is an active ingredient in 85 finished products listed with the FDA, under 6 names.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Brand and generic names
- Everolimus, Torpenz, Yulithira, Afinitor, Zortress, Afinitor Disperz
- Labelers
- Biocon Pharma Inc., Breckenridge Pharmaceutical, Inc., Novartis Pharmaceuticals Corporation, Hikma Pharmaceuticals USA Inc., Natco Pharma Limited, i3 Pharmaceuticals, LLC, Novugen Pharma (USA) LLC., Aurobindo Pharma Limited, NorthStar RxLLC, Ascend Laboratories, LLC
- Strengths
- Everolimus 5 mg/1; Everolimus 1 mg/1; Everolimus .5 mg/1; Everolimus 10 mg/1; Everolimus 2.5 mg/1; Everolimus 7.5 mg/1; Everolimus .25 mg/1; Everolimus .75 mg/1; Everolimus 2 mg/1; Everolimus 3 mg/1
- Dosage forms
- Tablet, Tablet, For suspension
- Routes
- Oral
- Drug classes (FDA established)
- Kinase Inhibitor, mTOR Inhibitor Immunosuppressant
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 139
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|
| Everolimus | Everolimus .25 mg/1 | TabletOral | i3 Pharmaceuticals, LLC | 72319-003 | 72319-0003-0272319-0003-60 | — |
| Everolimus | Everolimus 1 mg/1 | TabletOral | i3 Pharmaceuticals, LLC | 72319-017 | 72319-0017-0272319-0017-60 | — |
| Everolimus | Everolimus .5 mg/1 | TabletOral | i3 Pharmaceuticals, LLC | 72319-015 | 72319-0015-0272319-0015-60 | — |
| Everolimus | Everolimus .75 mg/1 | TabletOral | i3 Pharmaceuticals, LLC | 72319-016 | 72319-0016-0272319-0016-60 | — |
| everolimus | Everolimus 10 mg/1 | TabletOral | Novugen Pharma (USA) LLC. | 82293-033 | 82293-0033-1082293-0033-2182293-0033-31 | — |
| everolimus | Everolimus 2.5 mg/1 | TabletOral | Novugen Pharma (USA) LLC. | 82293-030 | 82293-0030-1082293-0030-2182293-0030-31 | — |
| everolimus | Everolimus 5 mg/1 | TabletOral | Novugen Pharma (USA) LLC. | 82293-031 | 82293-0031-1082293-0031-2182293-0031-31 | — |
| everolimus | Everolimus 7.5 mg/1 | TabletOral | Novugen Pharma (USA) LLC. | 82293-032 | 82293-0032-1082293-0032-2182293-0032-31 | — |
| everolimus | Everolimus .5 mg/1 | TabletOral | Aurobindo Pharma Limited | 59651-932 | 59651-0932-60 | — |
| everolimus | Everolimus .25 mg/1 | TabletOral | Aurobindo Pharma Limited | 59651-931 | 59651-0931-60 | — |
| everolimus | Everolimus .75 mg/1 | TabletOral | Aurobindo Pharma Limited | 59651-933 | 59651-0933-60 | — |
| everolimus | Everolimus 1 mg/1 | TabletOral | Aurobindo Pharma Limited | 59651-934 | 59651-0934-60 | — |
| Everolimus | Everolimus 2 mg/1 | Tablet, For suspensionOral | Biocon Pharma Inc. | 70377-090 | 70377-0090-1170377-0090-23 | — |
| Everolimus | Everolimus 3 mg/1 | Tablet, For suspensionOral | Biocon Pharma Inc. | 70377-091 | 70377-0091-1170377-0091-23 | — |
| Everolimus | Everolimus 5 mg/1 | Tablet, For suspensionOral | Biocon Pharma Inc. | 70377-092 | 70377-0092-1170377-0092-23 | — |
| Everolimuseverolimus tablets | Everolimus 1 mg/1 | TabletOral | Breckenridge Pharmaceutical, Inc. | 51991-985 | 51991-0985-0651991-0985-99 | — |
| Everolimus | Everolimus 5 mg/1 | Tablet, For suspensionOral | ANI Pharmaceuticals, Inc. | 70954-775 | 70954-0775-20 | — |
| Everolimus | Everolimus 2 mg/1 | Tablet, For suspensionOral | ANI Pharmaceuticals, Inc. | 70954-773 | 70954-0773-20 | — |
| Everolimus | Everolimus 3 mg/1 | Tablet, For suspensionOral | ANI Pharmaceuticals, Inc. | 70954-774 | 70954-0774-20 | — |
| Everolimus | Everolimus .25 mg/1 | TabletOral | Biocon Pharma Inc. | 70377-069 | 70377-0069-1170377-0069-12 | — |
| Everolimus | Everolimus .5 mg/1 | TabletOral | Biocon Pharma Inc. | 70377-070 | 70377-0070-1170377-0070-21 | — |
| Everolimus | Everolimus .75 mg/1 | TabletOral | Biocon Pharma Inc. | 70377-071 | 70377-0071-1170377-0071-12 | — |
| Everolimus | Everolimus 1 mg/1 | TabletOral | Biocon Pharma Inc. | 70377-112 | 70377-0112-1170377-0112-21 | — |
| Everolimus | Everolimus 2 mg/1 | Tablet, For suspensionOral | Breckenridge Pharmaceutical, Inc. | 51991-990 | 51991-0990-2851991-0990-77 | — |
| Everolimus | Everolimus 3 mg/1 | Tablet, For suspensionOral | Breckenridge Pharmaceutical, Inc. | 51991-991 | 51991-0991-2851991-0991-77 | — |
| Everolimus | Everolimus 5 mg/1 | Tablet, For suspensionOral | Breckenridge Pharmaceutical, Inc. | 51991-992 | 51991-0992-2851991-0992-77 | — |
| Everolimus | Everolimus 2 mg/1 | Tablet, For suspensionOral | Amneal Pharmaceuticals NY LLC | 60219-2279 | 60219-2279-02 | — |
| Everolimus | Everolimus 3 mg/1 | Tablet, For suspensionOral | Amneal Pharmaceuticals NY LLC | 60219-2280 | 60219-2280-02 | — |
| Everolimus | Everolimus 5 mg/1 | Tablet, For suspensionOral | Amneal Pharmaceuticals NY LLC | 60219-2281 | 60219-2281-02 | — |
| Everolimus | Everolimus 10 mg/1 | TabletOral | NorthStar RxLLC | 72603-257 | 72603-0257-01 | — |
| Everolimus | Everolimus 2.5 mg/1 | TabletOral | NorthStar RxLLC | 72603-254 | 72603-0254-01 | — |
| Everolimus | Everolimus 5 mg/1 | TabletOral | NorthStar RxLLC | 72603-255 | 72603-0255-01 | — |
| Everolimus | Everolimus 7.5 mg/1 | TabletOral | NorthStar RxLLC | 72603-256 | 72603-0256-01 | — |
| Everolimus | Everolimus .5 mg/1 | TabletOral | Par Health USA, LLC | 49884-159 | 49884-0159-02 | — |
| Everolimus | Everolimus 1 mg/1 | TabletOral | Par Health USA, LLC | 49884-283 | 49884-0283-02 | — |
| Everolimus | Everolimus .25 mg/1 | TabletOral | Ascend Laboratories, LLC | 67877-718 | 67877-0718-3167877-0718-60 | — |
| Everolimus | Everolimus .5 mg/1 | TabletOral | Ascend Laboratories, LLC | 67877-719 | 67877-0719-3167877-0719-60 | — |
| Everolimus | Everolimus .75 mg/1 | TabletOral | Ascend Laboratories, LLC | 67877-720 | 67877-0720-3167877-0720-60 | — |
| Everolimus | Everolimus 1 mg/1 | TabletOral | Ascend Laboratories, LLC | 67877-721 | 67877-0721-3167877-0721-60 | — |
| Everolimus | Everolimus 1 mg/1 | TabletOral | Hikma Pharmaceuticals USA Inc. | 0054-0604 | 00054-0604-21 | — |
| Everolimus | Everolimus 10 mg/1 | TabletOral | Natco Pharma Limited | 63850-0061 | 63850-0061-0163850-0061-04 | — |
| Everolimus | Everolimus 7.5 mg/1 | TabletOral | Biocon Pharma Inc. | 70377-012 | 70377-0012-1170377-0012-2270377-0012-23 | — |
| Everolimus | Everolimus 2.5 mg/1 | TabletOral | Biocon Pharma Inc. | 70377-010 | 70377-0010-1170377-0010-2270377-0010-23 | — |
| Everolimus | Everolimus 5 mg/1 | TabletOral | Biocon Pharma Inc. | 70377-011 | 70377-0011-1170377-0011-2270377-0011-23 | — |
| Everolimus | Everolimus 10 mg/1 | TabletOral | Biocon Pharma Inc. | 70377-013 | 70377-0013-1170377-0013-2270377-0013-23 | — |
| Torpenzeverolimus | Everolimus 2.5 mg/1 | TabletOral | Upsher-Smith Laboratories, LLC | 0245-0822 | 00245-0822-0400245-0822-30 | — |
| Torpenzeverolimus | Everolimus 5 mg/1 | TabletOral | Upsher-Smith Laboratories, LLC | 0245-0823 | 00245-0823-0400245-0823-30 | — |
| Torpenzeverolimus | Everolimus 7.5 mg/1 | TabletOral | Upsher-Smith Laboratories, LLC | 0245-0824 | 00245-0824-0400245-0824-30 | — |
| Torpenzeverolimus | Everolimus 10 mg/1 | TabletOral | Upsher-Smith Laboratories, LLC | 0245-0825 | 00245-0825-0400245-0825-30 | — |
| Everolimuseverolimus tablets | Everolimus .75 mg/1 | TabletOral | Breckenridge Pharmaceutical, Inc. | 51991-381 | 51991-0381-0651991-0381-60 | — |
Everolimus: common questions
- Which drugs contain Everolimus?
- Everolimus, Torpenz, Yulithira, Afinitor, Zortress, Afinitor Disperz.
- Is there a J-code for Everolimus?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.